Synlogic is a clinical-stage biopharmaceutical company that designs and develops medicines made from engineered probiotic bacteria, often called synthetic biotic medicines. These living medicines are intended to perform specific metabolic functions inside the body, and the company has studied them in areas such as inherited metabolic disorders and other serious conditions. Synlogic is based in Cambridge, Massachusetts, in the United States, and its work serves patients and clinicians in specialised medical fields.
Synlogic, Inc. trades under the code 0A8U on the London Exchange in UK, with its price quoted in US dollars (USD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #2762 of 3787 on the London Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for UK yet.
TrendFair
56/100
Mixed trend against its averages.
See the numbers →
Above 200-day average17.0%
From 52-week high-44.3%
MomentumFair
68/100
Typical recent returns for this exchange.
See the numbers →
3-month return40.6%
6-month return68.0%
12-month, skipping last month-34.8%
Stability (higher is calmer)Weak
7/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)100.1%
Worst drawdown, 1 year (smaller is calmer)-68.8%
LiquidityWeak
5/100
Thinly traded: prices can jump and exits can be hard.
See the numbers →
Avg daily value traded0.00M USD
Zero-volume days31.7%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for UK when fundamentals data for this market is added. All UK stocks.
52-wk range 0.540 – 1.795Daily closes, split-adjusted
Signals
50-day average0.897
200-day average0.855
Golden/death cross (60d)Golden, 3 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.056
Technical summary
Daily
Bullish
10 bullish · 1 neutral · 5 bearish
Weekly
Neutral
5 bullish · 1 neutral · 6 bearish
Monthly
Strongly bearish
1 bullish · 1 neutral · 6 bearish
Moving averages (daily)
SMA 10
1.12
Bearish
EMA 10
1.10
Bearish
SMA 20
1.16
Bearish
EMA 20
1.09
Bearish
SMA 50
0.90
Bullish
EMA 50
0.96
Bullish
SMA 100
0.76
Bullish
EMA 100
0.87
Bullish
SMA 200
0.85
Bullish
EMA 200
0.92
Bullish
Oscillators (daily)
RSI (14)
45.30
Neutral
MACD (12, 26)
0.04
Bullish
Momentum (12)
-18.70
Bearish
Stochastic %K (14)
0.00
Bullish
Williams %R (14)
-100.0
Bullish
CCI (20)
-206.5
Bullish
Pivot points (classic, last session)
S3
1.00
S2
1.00
S1
1.00
Pivot
1.00
R1
1.00
R2
1.00
R3
1.00
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in USD. Educational only, not financial advice.